French
The shift announced by Quebec will follow a similar approach to policies introduced in British Columbia, Alberta and recently in New Brunswick to transition patients who use a reference biologic to a biosimilar. This will contribute to substantial annual savings that can be reinvested in healthcare and innovative new drugs.
The transition will take place under the supervision of the attending physicians and patients will continue receiving safe and effective treatment. Sandoz Canada has a portfolio of six biosimilars (Omnitrope, Rixymio, Erelzi, Hyrimoz, Ziextenzo and Inclunox).
Sandoz Canada is committed to supporting patients, their healthcare professionals and the Quebec government throughout the transition period with quality biosimilar medicines, medical teams, physician and pharmacist advocacy teams, as well as proven patient support programs.
Aequus Provides General Update and First Quarter 2021 Financial Highlights streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
WINNIPEG Health Canada has issued a recall covering three types of blood pressure drugs from the class of medication known as sartans.’ A news release from Health Canada lists the three drugs recalled, which are produced by several manufacturers, as irbesartan, losartan and valsartan. Sartans are prescribed to treat patients with high blood pressure to help prevent heart attacks and stroke. They are also used in patients with heart failure or those who have had a recent heart attack. Health Canada says people who have been prescribed these medications should still keep taking them, unless a doctor or a health-care provider has advised you to stop.
decisivemarketsinsightsMay 10, 2021
The
Brown-Sequard Syndrome Treatment Market is expected to grow at a CAGR of 6.82% and is poised to reach US$XX Billion by 2027 as compared to US$XX Billion in 2020. The factors leading to this extraordinary growth is attributed to various market dynamics discussed in the report our experts have examined the market from a 360 degree perspective thereby producing a report which is definitely going to impact your business decisions.
In order to make a pre-order inquiry, kindly click on the link below:-
Summary of the Brown-Sequard Syndrome Treatment Market Report
In terms of both profitability and growth, how the global business environment is changing and also to ensure the continuous success in the global market, how the industry is confronting the challenges, a better understanding of the market participants is well provided in the market research industry report by Decisive Markets Insights. The